Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$737M |
| 2 |
American Tower
AMT
|
+$687M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$554M |
| 4 |
Abbott
ABT
|
+$553M |
| 5 |
SLB Ltd
SLB
|
+$449M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$1.06B |
| 2 |
Netflix
NFLX
|
+$816M |
| 3 |
Match Group
MTCH
|
+$678M |
| 4 |
NVIDIA
NVDA
|
+$611M |
| 5 |
Intuitive Surgical
ISRG
|
+$530M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.17% |
| 2 | Consumer Discretionary | 21.87% |
| 3 | Healthcare | 15.92% |
| 4 | Financials | 9.87% |
| 5 | Communication Services | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIXT
326
DELISTED
TELUS International
TIXT
| $17.7M | 0.02% |
706,968
+19,436
| +3% | +$459K |
|
327
Monolithic Power Systems
MPWR
$70.1B
| $16.9M | 0.02% |
44,037
-33,680
| -43% | -$14.2M |
|
328
Expedia Group
EXPE
$35.4B
| $16.9M | 0.02% |
178,053
+6,632
| +4% | +$939K |
|
|
LKFT
329
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
| $16.9M | 0.02% |
+302,250
| New | +$17.9M |
|
330
BCE
BCE
$20.2B
| $16.8M | 0.02% |
342,589
-844
| -0.2% | -$45.3K |
|
331
Cardlytics
CDLX
$21.7M
| $16.4M | 0.02% |
73,730
+14,554
| +25% | +$4.87M |
|
332
Service Corp International
SCI
$11.7B
| $16.4M | 0.02% |
237,785
+42,348
| +22% | +$2.9M |
|
333
James River Group Holdings
JRVR
$208M
| $16.4M | 0.02% |
662,682
+280,862
| +74% | +$6.87M |
|
|
SILK
334
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $16.4M | 0.02% |
450,282
-234,488
| -34% | -$8.52M |
|
335
Dentsply Sirona
XRAY
$2.68B
| $16.4M | 0.02% |
+457,930
| New | +$18.5M |
|
336
Regal Rexnord
RRX
$13.7B
| $16.3M | 0.02% |
143,369
+31,667
| +28% | +$4.03M |
|
337
Hamilton Lane
HLNE
$4.91B
| $16.3M | 0.02% |
242,011
+6,142
| +3% | +$423K |
|
|
AMK
338
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $16.1M | 0.02% |
859,346
+22,685
| +3% | +$454K |
|
339
Azenta
AZTA
$1.3B
| $16M | 0.02% |
221,912
+6,455
| +3% | +$482K |
|
340
Wingstop
WING
$3.53B
| $15.9M | 0.02% |
212,368
+5,483
| +3% | +$478K |
|
341
Suncor Energy
SU
$79.4B
| $15.5M | 0.02% |
443,068
-6,754
| -2% | -$246K |
|
342
Dow Inc
DOW
$21.9B
| $15.5M | 0.02% |
300,174
-21,267
| -7% | -$1.36M |
|
343
Howard Hughes
HHH
$3.81B
| $15.5M | 0.02% |
238,809
+6,694
| +3% | +$549K |
|
|
RCM
344
DELISTED
R1 RCM Inc. Common Stock
RCM
| $15.4M | 0.02% |
736,417
-34,341
| -4% | -$779K |
|
|
EXE
345
Expand Energy Corp
EXE
$21.8B
| $15M | 0.02% |
185,223
+42,153
| +29% | +$3.81M |
|
346
Integra LifeSciences
IART
$1.29B
| $14.9M | 0.01% |
275,402
+69,315
| +34% | +$4.16M |
|
|
CTRA
347
DELISTED
Coterra Energy
CTRA
| $14.8M | 0.01% |
573,345
-9,778
| -2% | -$297K |
|
348
Bunge Global
BG
$20.4B
| $14.7M | 0.01% |
162,166
+12,393
| +8% | +$1.38M |
|
349
Qiagen
QGEN
$8.54B
| $14.6M | 0.01% |
292,004
-14,739
| -5% | -$719K |
|
350
Chewy
CHWY
$9.25B
| $14.6M | 0.01% |
419,241
+93,053
| +29% | +$2.98M |
|
Similar funds
Jennison Associates's Q2 2022 Portfolio in Review
As of Q2 2022, Jennison Associates held 720 positions worth $100B, down 26% from $136B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Jennison Associates withdrew a net $3.7B in Q2 2022, closing 106 positions and reducing 265 holdings. Its most notable exit was Okta, an estimated $272M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in KBR worth $40.4M.
- Jennison Associates's largest Q2 2022 buy was KBR: 834,334 shares worth $40.4M.
- Jennison Associates added most to Eli Lilly in Q2 2022, an estimated $737M increase.
- Jennison Associates's biggest Q2 2022 reduction was Shopify, cutting an estimated $1.06B.
- Jennison Associates fully exited Okta in Q2 2022, selling an estimated $272M.
- Jennison Associates's ten largest holdings make up 41% of its $100B portfolio in Q2 2022.
- Jennison Associates opened 95 new positions and closed 106 in Q2 2022.
- Jennison Associates's portfolio value fell 26% quarter-over-quarter to $100B.
Based on Jennison Associates's 13F filing for Q2 2022, filed 2 Aug 2022.